Light-responsive ligands activate retinal neurons to repair vision loss in blind mice

June 5, 2017, JCI

Retinitis pigmentosa, age-related macular degeneration, and other retinal diseases lead to the deterioration of photoreceptors, the light-sensing cells in the eye. Eventually, this deterioration progresses to vision loss. Although there are several therapies in development to reverse retinal disease-related blindness, each is associated with safety concerns related to long-term stability. In mouse models of retinal disease, light-sensitive molecules known as photoswitches have been shown to restore light responses to damaged retinas. The ability to control the duration and application frequency of photoswitches, which are applied as a pharmacological therapy, makes them an attractive alternative approach to treating vision loss.

In this issue of the JCI, research led by Russ Van Gelder at the University of Washington describes diethylamino-azo-diethylamino (DAD), a third-generation photoswitch that is capable of restoring visual function in blind mice.

The design of DAD enables it to exist in charged and uncharged forms, which helps the light-sensitive molecule dissolve easily in solution and also ensures adequate delivery to retinal circuitry. DAD activates efficiently when exposed to blue or white light and rapidly reverts to its inactive form in darkness.

In mice, DAD application restored light responses primarily by photosensitizing bipolar cells, the retinal neurons that receive and integrate input from photoreceptors.

This preference for acting through give DAD distinct advantages over previously-developed photoswitches because taking advantage of existing retinal processing may enable better resolution of complex visual stimuli, such as movement.

Explore further: Stem cell therapy reverses blindness in animals with end-stage retinal degeneration

More information: Laura Laprell et al, Photopharmacological control of bipolar cells restores visual function in blind mice, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI92156

Related Stories

Stem cell therapy reverses blindness in animals with end-stage retinal degeneration

January 10, 2017
A stem cell-based transplantation approach that restores vision in blind mice moves closer to being tested in patients with end-stage retinal degeneration, according to a study published January 10 in Stem Cell Reports. The ...

New research could lead to restoring vision for sufferers of retinal disorders

June 29, 2016
Engineers and neuroscientists at the University of Sheffield have demonstrated for the first time that the cells in the retina carry out key processing tasks. This could pave the way for improving retinal implants and therefore ...

Photoreceptor cell death leads to blindness in CLN5 form of Neuronal Ceroid Lipofuscinosis

May 16, 2017
Researchers from the University of Eastern Finland have discovered a likely cause for visual impairment and eventual loss of vision in the Finnish variant of Neuronal Ceroid Lipofuscinosis (NCL). Visual impairment associated ...

Scientists deploy CRISPR to preserve photoreceptors in mice

March 14, 2017
Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study. The findings could lead to novel therapies for preventing vision loss from human diseases ...

AAQ chemical makes blind mice see; compound holds promise for treating humans

July 25, 2012
A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington in Seattle has discovered a chemical that temporarily restores some vision ...

Researchers identify treatment target for blinding diseases

September 28, 2016
New research published in Cell Reports identifies a potential treatment target for blinding diseases such as retinitis pigmentosa and advanced dry age-related macular degeneration. In the study, researchers at Washington ...

Recommended for you

Researchers reverse congenital blindness in mice

August 15, 2018
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward ...

Autoimmune response drives vision loss in glaucoma

August 10, 2018
A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive ...

Is too much screen time harming children's vision?

August 6, 2018
As children spend more time tethered to screens, there is increasing concern about potential harm to their visual development. Ophthalmologists—physicians who specialize in medical and surgical eye care—are seeing a marked ...

Researchers chart a course for AI-aided diagnosis of degenerative eye conditions

August 1, 2018
A team of researchers from Johns Hopkins is leading the way in understanding how the advent of electronic medical records with large image databases and advances in artificial intelligence with deep learning can offer medical ...

Derivative of turmeric eye drops could treat glaucoma

July 24, 2018
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.

Researchers are one step closer to developing eye drops to treat age-related macular degeneration

July 19, 2018
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.